GLUD1 and lung carcinoma: The glutamate-lysing enzyme glutamate dehydrogenase 1 (GDH1) confers anoikis resistance to lung cancer cells by enhancing the binding of substrates to AMPK, which makes lung cancer prone to metastasis [54].